Drought in Europe threatens crops and prices; why Romania could be an exception
European drought threatens agricultural output and crop supply across the region.
Source →The trace
How it reaches your house.
Starting from Sugar beet, we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
First impact
Sugar →Shortage riskEuropean drought directly hurts beet crops, so the beet input to sugar tightens even though sugar can also come from other sources.
93% confidenceSugar beet →Shortage riskGermany carries a 12% supply share here, and EU drought risk is concentrated in major German beet regions.
93% confidenceSugar beet →Shortage riskSüdzucker AGSZU
Südzucker depends on beet inputs, and a European drought can constrain the raw material it can process; the 12-month replacement horizon makes the hit material.
Hop 2
Germany →Prices riseMenthol (Natural & Synthetic L-Menthol)
Germany accounts for 65.6% of supply, so a drought-hit German production base would likely tighten this largely crop-linked input and push prices up.
62% confidenceTereos →Prices riseEuropean drought tightens wheat supplies, and Tereos's wheat-gluten input is directly crop-linked, so its procurement cost likely rises.
61% confidenceAGRANA →Prices riseA Europe-wide crop drought can tighten wheat availability and push up the price of AGRANA's vital wheat gluten input, though the effect is muted by the small dependency share and high substitutability.
Hop 3
Inhalation-Grade Lactose Monohydrate →Shortage riskMeggle Pharma also accounts for 40% of supply, so the same low-substitutability, long-replacement profile makes it highly exposed to input shortage.
84% confidenceInhalation-Grade Lactose Monohydrate →Shortage riskDFE Pharma supplies 40% of inhalation-grade lactose monohydrate, and with very low substitutability and a 60-month replacement lead time, a supply squeeze would hit it hard.
84% confidenceInhalation-Grade Lactose Monohydrate →Shortage riskHop 4
DFE Pharma →Shortage riskInhalation-Grade Lactose Monohydrate
DFE Pharma holds a 40% share of this input market, and the very low substitutability plus 60-month replacement time imply a company-level shock would translate into a material supply shortfall.
83% confidenceMeggle Pharma →Shortage riskInhalation-Grade Lactose Monohydrate
Meggle Pharma’s drought-linked production constraint would materially tighten supply of inhalation-grade lactose monohydrate, and the edge attributes imply a large, hard-to-replace share of supply.
80% confidenceOral care →Shortage risk
Where it lands
What you buy, and what you own.
Goods you buy
Sugar · Inhalers · Oral care · OTC medicines
In the MyPRIA app, this is checked against your own holdings.